BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28039450)

  • 1. Aberrant promoter methylation of hOGG1 may be associated with increased risk of non-small cell lung cancer.
    Qin H; Zhu J; Zeng Y; Du W; Shen D; Lei Z; Qian Q; Huang JA; Liu Z
    Oncotarget; 2017 Jan; 8(5):8330-8341. PubMed ID: 28039450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylated +322-327 CpG site decreases hOGG1 mRNA expression in non-small cell lung cancer.
    Zeng Y; Zhu J; Qin H; Shen D; Lei Z; Li W; Ding Z; Huang JA; Liu Z
    Oncol Rep; 2017 Jul; 38(1):529-537. PubMed ID: 28586012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association analysis of hOGG1 genetic variants and gastric cancer risk in a Chinese population.
    Lu J; Yin Y; Du M; Ma G; Ge Y; Zhang Q; Chu H; Tong N; Wang M; Qiu J; Zhang Z
    Oncotarget; 2016 Oct; 7(40):66061-66068. PubMed ID: 27603140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mutational analysis of hOGG1 gene promoter in patients with non-small cell lung cancer].
    Liu X; Zhao J; Liu R; Lei Z; You J; Zhou Q; Zhang HT
    Zhongguo Fei Ai Za Zhi; 2011 Mar; 14(3):199-204. PubMed ID: 21426660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hOGG1 Ser326Cys polymorphism and G:C-to-T:A mutations: no evidence for a role in tobacco-related non small cell lung cancer.
    Hu YC; Ahrendt SA
    Int J Cancer; 2005 Apr; 114(3):387-93. PubMed ID: 15551330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of the diagnostic role of FHIT promoter methylation in non-small cell lung cancer.
    Geng X; Pu W; Tan Y; Lu Z; Wang A; Tan L; Chen S; Guo S; Wang J; Chen X
    Oncotarget; 2017 Jan; 8(4):6845-6856. PubMed ID: 28036263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk.
    Park J; Chen L; Tockman MS; Elahi A; Lazarus P
    Pharmacogenetics; 2004 Feb; 14(2):103-9. PubMed ID: 15077011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
    Soria JC; Lee HY; Lee JI; Wang L; Issa JP; Kemp BL; Liu DD; Kurie JM; Mao L; Khuri FR
    Clin Cancer Res; 2002 May; 8(5):1178-84. PubMed ID: 12006535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Base Excision Repair Gene hOGG1 Ser326Cys Polymorphism with Susceptibility to Cervical Squamous Cell Carcinoma and High-Risk Human Papilloma Virus Infection in a Chinese Population.
    Chen H; Wang H; Liu J; Cheng Q; Chen X; Ye F
    Genet Test Mol Biomarkers; 2019 Feb; 23(2):138-144. PubMed ID: 30648893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XAF1 is frequently methylated in human esophageal cancer.
    Chen XY; He QY; Guo MZ
    World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of hOGG1-Cys variants with occurrence of p53 and EGFR deletion mutations in non-small cell lung cancer.
    Chen MJ; Shen CJ; Wang L; Chen PM; Chen CY; Lee H
    Thorac Cancer; 2021 Feb; 12(4):534-538. PubMed ID: 33372419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hOGG1 Ser326Cys polymorphism is associated with risk of bladder cancer in a Chinese population: a case-control study.
    Ma L; Chu H; Wang M; Shi D; Zhong D; Li P; Tong N; Yin C; Zhang Z
    Cancer Sci; 2012 Jul; 103(7):1215-20. PubMed ID: 22463382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hOGG1 Ser326Cys polymorphism and susceptibility to gallbladder cancer in a Chinese population.
    Jiao X; Huang J; Wu S; Lv M; Hu Y; Jianfu ; Su X; Luo C; Ce B
    Int J Cancer; 2007 Aug; 121(3):501-5. PubMed ID: 17417784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers.
    Drzewiecka H; Gałęcki B; Jarmołowska-Jurczyszyn D; Kluk A; Dyszkiewicz W; Jagodziński PP
    J Cancer Res Clin Oncol; 2016 Sep; 142(9):1927-46. PubMed ID: 27393180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG island methylator phenotype involving chromosome 3p confers an increased risk of non-small cell lung cancer.
    Liu Z; Li W; Lei Z; Zhao J; Chen XF; Liu R; Peng X; Wu ZH; Chen J; Liu H; Zhou QH; Zhang HT
    J Thorac Oncol; 2010 Jun; 5(6):790-7. PubMed ID: 20521346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hOGG1 Ser326Cys Gene Polymorphism and Breast Cancer Risk in Saudi Population.
    Alanazi M; Pathan AAK; Shaik JP; Alhadheq A; Khan Z; Khan W; Al Naeem A; Parine NR
    Pathol Oncol Res; 2017 Jul; 23(3):525-535. PubMed ID: 27822728
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Hsu PC; Chen CC; Tzeng HE; Hsu YN; Kuo CC; Lin ML; Chang WS; Wang YC; Tsai CW; Pei JS; Bau DT
    In Vivo; 2019; 33(4):1081-1086. PubMed ID: 31280195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common CD55 rs2564978 variant is associated with the susceptibility of non-small cell lung cancer.
    Zhang Y; Zhang Z; Cao L; Lin J; Yang Z; Zhang X
    Oncotarget; 2017 Jan; 8(4):6216-6221. PubMed ID: 28008159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of 5-Aza-2-deoxycytidine on DNA methylation of anti-oncogenes in non-small cell lung cancer cells].
    Fang HL; Yu ZC; Zhu HB; Jin YT
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):658-63. PubMed ID: 23159077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation-mediated loss of SFRP2 enhances invasiveness of non-small cell lung cancer cells.
    Zhang X; Rong X; Chen Y; Su L
    Hum Exp Toxicol; 2018 Feb; 37(2):155-162. PubMed ID: 29320940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.